Loading...



Shopping cart processing ...
0
Your cart0
Products 0
Price $0.00
Bestsellers Pill categories
Customer Support 24/7
usa canada USA
uk UK
au AU
Live Chat 24/7
Menu
Customer Support 24/7
USA/Canada Toll Free USA
UK UK
AUS AU
Customer Support 24/7
usacanada USA
uk UK
au AU
We accept
  • Visa
  • MasterCard
  • Amex
  • JCB
Currency
USD
Your cart: $0.00 (0 items)
Checkout

Categories list

Choosing us you get:

  • Reliable supplier
  • Low Internet prices
  • Free bonus pills
  • Discount on all future orders
  • Discreet package
  • SSL secure orders
Worldwide Shipping!

Testimonials:

  • Dennis Euler Salinas, CA, USA
    I appreciate your individual approach to the client and quick servicing. All I can wish you is to go forward not to stop at existing successes and stay as cool as you are now.
More info »

Hydrea

Hydrea
Hydrea is indicated for the treatment of chronic myeloid leukemia. melanoma, ovarian cancer, cervical cancer, choriocarcinoma of the uterus, head and neck tumors brain tumor, erythremia.

Brand: Hydroxyurea

Availability: In Stock
Average Delivery Time: 9 Days
Exp. Date: November 2023
View product image
Package Price Per pill Save Order
Hydrea 500 mg
240 pills - 500 mg
+ 12 free Viagra 100 mg, 7% discount for future orders
$374.41 $1.56 $169.51 Add to cart
120 pills - 500 mg
+ 4 free Viagra 100 mg, 3% discount for future orders
$195.99 $1.63 $75.97 Add to cart
90 pills - 500 mg
+ 4 free Viagra 100 mg, 3% discount for future orders
$151.93 $1.69 $52.04 Add to cart
60 pills - 500 mg
+ 4 free Viagra 100 mg, 3% discount for future orders
$111.95 $1.87 $24.03 Add to cart
30 pills - 500 mg $67.99 $2.27 No Add to cart

Product description

Pharmacological action of the Hydrea®

Buy Hydrea in Canada

Antineoplastic agent. The proposed mechanism of action is to inhibit DNA synthesis. Does not affect protein and RNA synthesis.

Pharmacokinetics

After oral administration, it is well absorbed from the gastrointestinal tract. Penetrates the BBB. Metabolized in the liver. It is excreted mainly by the kidneys (80%). T1/2 -. 3-4 hours

Indications preparation Hydrea®

Hydrea packaging

chronic and acute myeloid leukemia, blast crisis in chronic myeloid leukemia, melanoma, breast carcinoma and gastric, head and neck tumors (if impossible or only partially possible resection or radiation), cancer ovaries, uterine choriocarcinoma, acute lymphoblastic leukemia in children (relapses), lung cancer. It is also used in conjunction with radiation therapy (to increase its effectiveness) for cervical cancer and brain tumors.

Interaction

Increases the effect of cytarabine, weakens - 5-fluorouracil and methotrexate. With the simultaneous administration of antidepressants, antihistamines, barbiturates, sedatives, hypnotics, drugs and alcohol, the inhibition of the reaction rate increases.

Dosing and Administration of the drug Hydrea®

Inside, before meals. Treatment is usually carried out in periodic courses. At 80 mg / kg once every 3 days or daily at 20-30 mg / kg once (doses are based on actual or normal body weight, with the smaller of the indicated values ​​being used). In elderly patients, it is advisable to use smaller doses. During treatment, patients should consume a sufficient amount of fluids.

Contraindications to use

Leukopenia less than 2500 / μl, thrombocytopenia less than 100,000 / μl, severe anemia, pregnancy, hypersensitivity to hydroxycarbamide.

Use during pregnancy and lactation

Hydroxycarbamide is contraindicated in pregnancy. If necessary, use during lactation should stop breastfeeding.

Women of childbearing age receiving hydroxycarbamide therapy should use reliable methods of contraception.

In experimental studies , the teratogenic and embryotoxic effects of hydroxycarbamide have been established.

Application for impaired renal function

Care must be taken in patients with severe impaired renal function.

Use in elderly patients

Elderly patients may require adjustment of the dosage regimen.

Special instructions

Care must be taken in patients with severe renal impairment.

It is not recommended to use hydroxycarbamide in patients with chickenpox (including recently transferred or after contact with sick), herpes zoster and other acute infectious diseases.

Elderly patients may require a dosage adjustment.

When using hydroxycarbamide in patients with gout or nephrolithiasis, the risk of hyperuricemia increases.

The combination with radiation therapy can lead to an increase in side effects associated with myelodepression and damage to the gastric mucosa. Radiation-induced erythema may increase. Nausea, vomiting, anorexia caused by combined use with radiation therapy, as a result of temporary withdrawal of hydroxycarbamide, may disappear.

Before starting and during treatment, a complete blood picture should be determined, including an examination of the bone marrow, as well as kidney and liver function. Repeat the blood test at least 1 time / week. With a decrease in the number of leukocytes less than 2500 / μl, and platelets less than 100,000 / μl, treatment should be discontinued until the normal values ​​of these parameters are restored. Possible changes in ESR (often increased).

With the development of anemia, it should be treated without interrupting the course of hydroxycarbamide, with the help of replacement transfusions of erythrocyte mass.

Changes in biochemical parameters are possible: an increase in the concentration in the blood of urea, creatinine, uric acid, an increase in the activity of hepatic transaminases.

It is not recommended to vaccinate patients and their families.

Drug interaction

Possible increased myelosuppression in the case of previous therapy with cytotoxic drugs.

Side effect

From the hematopoietic system: leukopenia, thrombocytopenia, anemia.

From the digestive system: stomatitis, anorexia, nausea, vomiting, diarrhea, constipation; rarely - liver dysfunction.

From the side of the central nervous system: a feeling of fatigue, headache, drowsiness, dizziness, hallucinations, convulsions.

From the respiratory system: in some cases - diffuse pulmonary infiltrates, accompanied by fever and shortness of breath.

From the urinary system: difficulty urinating; rarely - impaired renal function.

Dermatological reactions: alopecia, maculopapular rash, erythema.

Others: fever, chills.